Results 201 to 210 of about 1,138,740 (267)

Outcome of illustrated information leaflet on correct usage of asthma-metered dose inhaler. [PDF]

open access: yesAfr J Prim Health Care Fam Med, 2019
Wrench W   +3 more
europepmc   +1 more source

The rejuvenated pressurised metered dose inhaler

Expert Opinion on Drug Delivery, 2007
The pressurised metered-dose inhaler (pMDI) has now been available for 50 years. Once regarded as an inefficient and difficult-to-use device, the technology has evolved significantly over the last few years, particularly since the introduction of novel formulations containing hydrofluoroalkane (HFA) propellants.
John, Bell, Steve, Newman
exaly   +3 more sources

Metered dose inhalers: A need for dose counters

Respirology, 2005
Objectives:  This study investigated the ability of patients to assess when a metered dose inhaler (MDI) is empty.Methodology:  A total of 17 patients assessed, by shaking, the number of doses remaining in a salbutamol MDI that had been partially emptied.
Shaun, Holt   +4 more
openaire   +2 more sources

Floating Patterns of Metered Dose Inhalers

Journal of Asthma, 1997
As long as metered dose inhalers have existed, patients have sought a reliable method to determine if a given canister was still potent. Concerning beta agonists, the answer to this question may be lifesaving. Issues of compliance have made dating canisters or counting doses impractical.
B L, Wolf, K R, Cochran
openaire   +2 more sources

Nonprescription Epinephrine Metered-Dose Inhaler: To Be or Not To Be

Pediatric Allergy, Immunology, and Pulmonology, 2014
A new product, Epinephrine HFA, is being considered by the Food and Drug Administration (FDA) for marketing approval as a nonprescription bronchodilator inhaler for the treatment of the “temporary relief of mild symptoms of intermittent asthma in adults and children 12 years of age and older.” This product would serve as a ...
Kathryn, Blake, Hengameh, Raissy
openaire   +2 more sources

The Continued Need for Metered Dose Inhalers

Journal of Aerosol Medicine, 1995
The metered dose inhaler (MDI) is currently the most widely used device in the treatment of adult asthma. It is the delivery system of choice in general practice throughout the world where both MDIs and powder inhalers are available. Up to 70% of all UK adult asthma prescriptions are for an MDI and worldwide the figures are likely to be higher. The MDI
openaire   +2 more sources

Inability of Physicians to Use Metered-Dose Inhalers

Journal of Asthma, 1997
The effectiveness of antiasthmatic therapy with metered-dose inhalers (MDIs) is usually limited by defective inhalational technique. This study surveyed the MDI inhalation performance and knowledge of 100 physicians whose performance (demarcated into six stages) and knowledge scores correlated (r = 0.33, p < 0.001).
Ip, M   +8 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy